p53 regulates ERK activation in carboplatin induced apoptosis in cervical carcinoma: A novel target of p53 in apoptosis

FEBS Letters

Volumn 581, Issue 2, 2007, Pages 289-295

  Singh, Sandeep ^a   Upadhyay, Ankur Kumar ^a   Ajay, Amrendra Kumar ^a   Bhat, Manoj Kumar ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Apoptosis; Carboplatin; Extracellular recognition kinase; p53

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CARBOPLATIN; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; PIFITHRIN ALPHA; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL STRAIN; CELL STRAIN CASKI; CELL STRAIN SIHA; DNA DAMAGE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN TARGETING; REGULATORY MECHANISM; TRANSACTIVATION; UPREGULATION; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARBOPLATIN; CARCINOMA; CELL LINE, TUMOR; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 33846277976     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.12.035     Document Type: Article

References (44)

1. Bellon S., Coleman J., and Lippard S. DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II). Biochemistry 30 (1991) 8026-8035
2. Seger R., and Krebs E.G. The MAPK signaling cascade. FASEB J. 9 (1995) 726
3. Waskiewicz A.J., and Cooper J.A. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell Biol. 7 (1995) 798-805
4. Tibbles L.A., and Woodgett J.R. The stress-activated protein kinase pathways. Cell. Mol. Life Sci. 55 (1999) 1230-1254
5. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268 (1993) 14553-14556
6. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
7. Werlen G., Hausmann B., Naeher D., and Palmer E. Signaling life and death in the thymus: timing is everything. Science 299 (2003) 1859
8. Tang D., Wu D., Hirao A., Lahti J.M., Liu L., Mazza B., Kidd V.J., Mak T.W., and Ingram A.J. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J. Biol. Chem. 277 (2002) 12710-12717
9. Wang X., Martindale J.L., and Holbrook N.J. Requirement for ERK activation in Cisplatin-induced apoptosis. J. Biol. Chem. 275 (2000) 39435-39443
10. Schweyer S., Soruri A., Meschter O., Heintze A., Zschunke F., Miosge N., Thelen P., Schlott T., Radzun H.J., and Fayyazi A. Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation. Br. J. Cancer 91 (2004) 589-598
11. Johnson G.L., and Vaillancourt R.R. Sequential protein kinase reactions controlling cell growth and differentiation. Curr. Opin. Cell Biol. 6 (1994) 230-238
12. Robinson M.J., and Cobb M.H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9 (1997) 180-186
13. He H., Wang X., Gorospe M., Holbrook N.J., and Trush M.A. Phorbol ester-induced mononuclear cell differentiation is blocked by the mitogen-activated protein kinase kinase (MEK) inhibitor PD98059. Cell Growth Differ. 10 (1999) 307-315
14. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
15. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 (2002) 342-350
16. Koivusalo R., Krausz E., Ruotsalainen P., Helenius H., and Hietanen S. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand. Cancer Res. 62 (2002) 7364-7371
17. Yim E.K., Lee K.H., Bae J.S., Namkoong S.E., Um S.J., and Park J.S. Proteomic analysis of antiproliferative effects by treatment of 5-fluorouracil in cervical cancer cells. DNA Cell Biol. 23 (2004) 769-776
18. Upadhyay A.K., Singh S., Chhipa R.R., Vijayakumar M.V., Ajay A.K., and Bhat M.K. Methyl-beta-cyclodextrin enhances the susceptibility of human breast cancer cells to carboplatin and 5-fluorouracil: involvement of Akt, NF-kappaB and Bcl-2. Toxicol. Appl. Pharmacol. 216 (2006) 177-185
19. Singh S., Chhipa R.R., Vijayakumar M.V., and Bhat M.K. DNA damaging drugs-induced down regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells. Cancer Lett. 236 (2006) 213-221
20. Dudley D.T., Pang L., Decker S.J., Bridges A.J., and Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92 (1995) 7686-7689
21. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., and Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273 (1998) 18623-18632
22. Coffer P.J., Burgering B.M., Peppelenbosch M.P., Bos J.L., and Kruijer W. UV activation of receptor tyrosine kinase activity. Oncogene 11 (1995) 561-563
23. Benhar M., Engelberg D., and Levitzki A. Cisplatin-induced activation of the EGF receptor. Oncogene 21 (2002) 8723-8731
24. Kitagawa D., Tanemura S., Ohta S., Shimizu N., Seo J., Nishitai G., Watanabe T., Nakagawa K., Kishimoto H., Wada T., Tezuka T., Yamamoto T., Nishina H., and Katada T. Activation of extracellular signal-regulated kinase by ultraviolet is mediated through Src-dependent epidermal growth factor receptor phosphorylation. Its implication in an anti-apoptotic function. J. Biol. Chem. 277 (2002) 366-371
25. Wells A. EGF receptor. Int. J. Biochem. Cell Biol. 31 (1999) 637-643
26. Ciardiello F., and Tortora G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin. Cancer Res. 7 (2001) 2958-2970
27. Bos M., Mendelsohn J., Kim Y.M., Albanell J., Fry D.W., and Baselga J. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin. Cancer Res. 3 (1997) 2099-2106
28. Komarov P.G., Komarova E.A., Kondratov R.V., Christov-Tselkov K., Coon J.S., Chernov M.V., and Gudkov A.V. A Chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285 (1999) 1733-1737
29. Lee S.W., Fang L., Igarashi M., Ouchi T., Lu K.P., and Aaronson S.A. Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53. Proc. Natl. Acad. Sci. USA 97 (2000) 8302-8305
30. 2. J. Biol. Chem. 271 (1996) 4138-4142
31. Wang X., Martindale J.L., Liu Y., and Holbrook N.J. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J. 333 (1998) 291-300
32. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
33. Chen Y.R., Wang X., Templeton D., Davis R.J., and Tan T.H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γradiation. Duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271 (1996) 31929-31936
34. Graves J.D., Draves K.E., Craxton A., Saklatvala J., Krebs E.G., and Clark E.A. Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. Proc. Natl. Acad. Sci. USA 93 (1996) 13814-13818
35. Brenner B., Koppenhoefer U., Weinstock C., Linderkamp O., Lang F., and Gulbins E. Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J. Biol. Chem. 272 (1997) 22173-22181
36. Hayakawa J., Ohmichi M., Kurachi H., Ikegami H., Kimura A., Matsuoka T., Jikihara H., Mercola D., and Murata Y. Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. J. Biol. Chem. 274 (1999) 31648-31654
37. Persons D.L., Yazlovitskaya E.M., Cui W., and Pelling J.C. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin. Cancer Res. 5 (1999) 1007-1014
38. Yeh P.Y., Chuang S.E., Yeh K.H., Song Y.C., and Cheng A.L. Nuclear extracellular signal regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin. Biochem. Biophys. Res. Commun. 284 (2001) 880-886
39. Armstrong M.B., Bian X., Liu Y., Subramanian C., Ratanaproeksa A.B., Shao F., Yu V.C., Kwok R.P., Opipari Jr. A.W., and Castle V.P. Signaling from p53 to NF-kappaB determines the chemotherapy responsiveness of neuroblastoma. Neoplasia 8 (2006) 967-977
40. Yin Y., Liu Y.X., Jin Y.J., Hall E.J., and Barrett J.C. PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression. Nature 422 (2003) 527-531
41. Li M., Zhou J.Y., Ge Y., Matherly L.H., and Wu G.S. The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation. J. Biol. Chem. 278 (2003) 41059-41068
42. Ueda K., Arakawa H., and Nakamura Y. Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53. Oncogene 22 (2003) 5586-5591
43. Takekawa M., Adachi M., Nakahata A., Nakayama I., Itoh F., Tsukuda H., Taya Y., and Imai K. p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J. 19 (2000) 6517-6526
44. Choi J., Nannenga B., Demidov O.N., Bulavin D.V., Cooney A., Brayton C., Zhang Y., Mbawuike I.N., Bradley A., Appella E., and Donehower L.A. Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control. Mol. Cell. Biol. 22 (2002) 1094-1105